ZYUS Life Sciences Corporation (CVE:ZYU – Free Report) – Investment analysts at Stifel Canada issued their FY2025 EPS estimates for ZYUS Life Sciences in a note issued to investors on Thursday, September 19th. Stifel Canada analyst J. Keywood expects that the company will earn ($0.38) per share for the year.
ZYUS Life Sciences Stock Performance
ZYUS Life Sciences (CVE:ZYU – Get Free Report) last announced its quarterly earnings data on Wednesday, August 28th. The company reported C($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of C($0.08) by C$0.01. The business had revenue of C$0.12 million for the quarter, compared to analysts’ expectations of C$0.11 million.
Read More
- Five stocks we like better than ZYUS Life Sciences
- How to Use the MarketBeat Dividend Calculator
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- How to Effectively Use the MarketBeat Ratings Screener
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Find and Profitably Trade Stocks at 52-Week Lows
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for ZYUS Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZYUS Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
